Affiliation:
1. Department of Medicine 1, Kussmaul Campus for Medical Research, University of Erlangen-Nürnberg, 91052 Erlangen, Germany
2. Medical Immunology Campus Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, 91052 Erlangen, Germany
Abstract
Inflammatory bowel disease (IBD) is an autoimmune disease that leads to severe bowel symptoms and complications. Currently, there is no effective treatment, and the exact cause of IBD remains unclear. In the last decades, numerous studies have confirmed that flavonoids can have a positive impact on the treatment of IBD. Therefore, this study investigated the protective effect of a flavonoid combination of apigenin and epigallocatechin-3-gallate (EGCG) on IBD. In vitro studies in which Caco-2 cell monolayers were incubated with different concentrations of flavonoids found that the flavonoid-treated group exhibited increased transepithelial electrical resistance (TEER) at high concentrations, indicating a protective effect on the barrier function of the intestinal epithelium. In vivo studies showed that flavonoids significantly attenuated inflammatory levels in both chronic and acute hapten-mediated experimental colitis models in a time- and dose-dependent manner. In addition, the activity of myeloperoxidase (MPO) and the level of proinflammatory cytokines in the colon tissue were significantly reduced. Interestingly, the levels of anti-inflammatory cytokines were also dramatically increased. Finally, flavonoids were found to positively modulate the composition of the gut microbiota in the colon. Therefore, a combination of flavonoids could be a promising therapeutic agent for the future adjunctive treatment of IBD.
Funder
Dazhou central hospital, China
IZKF Erlangen
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference35 articles.
1. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020;Nakase;J. Gastroenterol.,2021
2. The immunological and genetic basis of inflammatory bowel disease;Bouma;Nat. Rev. Immunol.,2003
3. The four epidemiological stages in the global evolution of inflammatory bowel disease;Kaplan;Nat. Rev. Gastroenterol. Hepatol.,2021
4. A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease;Guan;J. Immunol. Res.,2019
5. (2023, March 03). (IBD) Ibd: Mayo Clinic 2022. Available online: https://wwwmayoclinicorg/diseases-conditions/inflammatory-bowel-disease/diagnosis-treatment/drc-20353320.